EAGLE PHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Eagle Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $421K, a 12.3% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.51M, a 7.11% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.41M, a 6.35% increase from 2020.
  • Eagle Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $1.32M, a 39% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.51M +$100K +7.11% Jan 1, 2022 Dec 31, 2022 10-Q/A 2023-08-09
2021 $1.41M +$84K +6.35% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $1.32M +$371K +39% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $952K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.